iTherX
San Diego
About iTherX
iTherX is a clinical stage pharmaceutical company focused on the discovery and development of innovative treatments for Hepatitis C. This is a disease that affects almost 3% of the world's population, and is the major cause of chronic liver disease, cirrhosis, liver failure and primary liver cancer. Currently there is only a single mode of therapy and less than 5% of patients can be successfully treated.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $6.0M
- Last round: Series Unknown (Nov 2011)
- Website: itxpharma.com
- Phone: +1 858-222-1568
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/itherx-1632101 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.